Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/01/23 → 2/01/28 |
A Phase I/II Double-Blind, Randomised and Controlled-to-Open-Label Study Assessing the Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in Young People with Autism Spectrum Disorder
- Fahey, Michael (Primary Chief Investigator (PCI))
Project: Research